Primevax Immuno-Oncology

Clinical stage immuno-oncology treating late stage cancer. #oncolyticvirus #virotherapy @oncolyticvirotheray #immunotherapy #biotechstartup

[Primevax Immuno-Oncology @PrimeVax]

Team is talking now #cancer and #nfts #oncolyticvirus #virotherapy #immunooncology #dengue @CancerNft https://t.co/3EMpP2nRhY

[Primevax Immuno-Oncology @PrimeVax]

Looking forward! #virotherapy #oncolyticvirus #immunooncology #cancer #Denguevaccine #primevax

[World Vaccine Congress @vaccinenation]

Join the @vaccinenation #WVIC this November to see "Using Dengue fever to treat cancer" with @PrimeVax. #vaccines

Book now & save on your ticket here: https://t.co/7DyFaeTHgQ

[Parker Institute for Cancer Immunotherapy @parkerici]

1/ On #DayofImmunology🔬 we're sharing three reasons why one of our favorite immune cells is the DENDRITIC CELL:

1️⃣ They are the professional antigen presenting cells capable of taking up, processing and presenting antigens to CD4+ and CD8+ T cells.

[Primevax Immuno-Oncology @PrimeVax]

Congrats to our SAB members in this pic! Thank you for your extraordinary service #BernieFox #FrancoMarincola #AlessandraCesano #SITC2020 #Immunotherapy #oncology #oncolyticvirus 👏

[Society for Immunotherapy of Cancer @sitcancer]

Congratulations to today’s #SITC2020 Anniversary Award recipients! It is without question that SITC celebrates 35 years of harnessing the immune system to transform cancer outcomes because of the efforts put forth by many, including these remarkable individuals.

[Primevax Immuno-Oncology @PrimeVax]

Thx @Mass_CONNECT and @massbio Thrilled to be in the final cohort! #biotech #immunooncology #Immunotherapy #cancer #oncolyticvirus #dengue

[MassCONNECT @Mass_CONNECT]

Learn more about the 3 #lifesciences #startups we are thrilled to be working with this fall! cc @BenRFreedman @PrimeVax

[Primevax Immuno-Oncology @PrimeVax]

We are honored to be among the other finalists! #BuzzofBio #Immunotherapy #oncology #innovation #oncolyticvirus

[BIO One-on-One Partnering @bio1x1]

Meet #BuzzofBIO 'Early Stage Entrepreneur' finalists Allander Biotechnologies, LLC, Aurora Oncology, Inc., Curevo Vaccine, @ExcisionBiotx, @MAIABiotech, @OncoHeroesBio, @oxidien, @PrimeVax
Starton Therapeutics, TRIO Pharmaceuticals, Inc.

Cast your vote-->https://t.co/m4HO0Aa8zt

[Primevax Immuno-Oncology @PrimeVax]

We are a finalist! Please vote for #PrimeVax in the #BuzzofBIO contest - Early Stage Entrepreneur Category! vote by September 17 to help us win! https://t.co/ksLfPEwEnO @IAmBiotech @BernardAFox @AndrewZloza #oncolyticvirus #immunooncology #immunotherapy #latestagecancers

[Joshua Duder @JoshuaRDuder]

#getyourkitsout #kitnerd challenge Day 19 @Aztecafc15 (is this a matchday shirt or training top?)

[Primevax Immuno-Oncology @PrimeVax]

PrimeVax Immuno-Oncology Receives IND Permission from FDA For Use of US Army’s Dengue Virus to Treat Cancer https://t.co/CtPF7jwM2i

[Primevax Immuno-Oncology @PrimeVax]

We are proud to announce our exclusive licensing agreement with the #USArmy to use their #dengue #virus to treat #cancer! Read more here: https://t.co/e7XXxh7Ftp

[Primevax Immuno-Oncology @PrimeVax]

Our ongoing fight against #cancer continues as we launch our clinicaltrials,gov listing! Learn more at: https://t.co/4rhdtdEBW7

[Primevax Immuno-Oncology @PrimeVax]

We applaud our industry colleagues on adopting new viral approaches to treating cancer. #Immunotherapy #oncology #virus #medicine #sitc #ASCO

[Nature Biotechnology @NatureBiotech]

Checkpoint inhibitors go viral. In 2018, three major pharmas bought biotechs developing oncolytic viruses: @Merck acquired Viralytics in February, @JNJNews acquired BeneVir in May and @Boehringer acquired ViraTherapeutics in Sept https://t.co/urIW5vv8sY

[Primevax Immuno-Oncology @PrimeVax]

PrimeVax got our IND permitted by FDA! We are starting trials soon. https://t.co/qNjBsFkxGJ

[Primevax Immuno-Oncology @PrimeVax]

PrimeVax receives FDA clearance to begin first human clinical trial https://t.co/LR0y4ZuhbB

[Primevax Immuno-Oncology @PrimeVax]

PrimeVax will be presenting next week at the World Immunotherapy Congress in San Diego: https://t.co/xbvhoZxLp2

[Primevax Immuno-Oncology @PrimeVax]

PrimeVax was featured in AngelMD's investment blog: https://t.co/Ea5q2DQJPh

[Primevax Immuno-Oncology @PrimeVax]

PrimeVax's CEO Tony Chen will be presenting next week at the Biocom Life Sciences Conference in San Diego: https://t.co/CBlfbGrgX3

[Primevax Immuno-Oncology @PrimeVax]

PrimeVax was featured in @BBC_Future: http://t.co/jlQkphwmJq
Thanks @d_a_robson